anti-GIP antibody product blog
Tags: Antibody; GIP; Monoclonal Antibody; Gastric Inhibitory Polypeptide (GIP); anti-GIP antibody;
The GIP gip (Catalog #MBS2090985) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Gastric Inhibitory Polypeptide (GIP) can be used in a range of immunoassay formats including, but not limited to, ELISA, CLIA. / Immunohistochemistry (IHC-Fr), Immunocytochemistry (ICC), Immunoprecipitation (IP) (predicted).Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user. Researchers should empirically determine the suitability of the GIP gip for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The GIP gip product has the following accession number(s) (GI #4758436) (NCBI Accession #NP_004114.1) (Uniprot Accession #P09681). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Source: Monoclonal antibody preparation
Label: Biotin
Unconjugated Antibody: MBS2025683. Traits: Liquid
Immunogen: Synthetic Peptide, GIP conjugated to OVA.
Target peptide sequence: FISDYSIAMDKI. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing GIP are readily searchable from our website. Different antibodies against the same target such as GIP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Carcinoma, Diabetes Complications, Diabetes Mellitus, Type 2, Drug Toxicity, Hyperplasia, Kidney Diseases, Neoplasms, Neurologic Manifestations, Weight Gain, Weight Loss are some of the diseases may be linked to Biotin-Linked Monoclonal Antibody to Gastric Inhibitory Polypeptide (GIP). Intestine, Stomach tissues are correlated with this protein. GIP also interacts with the following gene(s): BAX, DPP4, GATA4, GIPR, RETN.